CellaVision AB
SWB:C26

Watchlist Manager
CellaVision AB Logo
CellaVision AB
SWB:C26
Watchlist
Price: 13.1 EUR 7.55%
Market Cap: €499.3m

Wall St Price Targets

C26 Price Targets Summary
CellaVision AB

Wall Street analysts forecast C26 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for C26 is 14.99 EUR with a low forecast of 14.56 EUR and a high forecast of 15.72 EUR.

Lowest Forecast
Price Target
14.56 EUR
11% Upside
Average Forecast
Price Target
14.99 EUR
14% Upside
Highest Forecast
Price Target
15.72 EUR
20% Upside
CellaVision AB Competitors:
Price Targets
PAT
Panthera Resources PLC
280% Upside
NESR
National Energy Services Reunited Corp
2% Upside
XO
Exotic Food PCL
-25% Downside
CMTG
Claros Mortgage Trust Inc
58% Upside

Revenue
Forecast

12% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
12% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 8%.

Gross Profit
Forecast

13% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
13% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 13%. The projected CAGR for the next 3 years is 12%.

Operating Income
Forecast

19% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
19% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 19%. The projected CAGR for the next 3 years is 9%.

Pre-Tax Income
Forecast

20% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
20% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 20%. The projected CAGR for the next 3 years is 18%.

Net Income
Forecast

28% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
28% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 28%. The projected CAGR for the next 3 years is 18%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is C26's stock price target?
Price Target
14.99 EUR

According to Wall Street analysts, the average 1-year price target for C26 is 14.99 EUR with a low forecast of 14.56 EUR and a high forecast of 15.72 EUR.

What is the Revenue forecast for CellaVision AB?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 8%.

What is the Gross Profit forecast for CellaVision AB?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 13%. The projected CAGR for the next 3 years is 12%.

What is the Operating Income forecast for CellaVision AB?
Projected CAGR
9%

Over the last 13 years, the compound annual growth rate for Operating Income has been 19%. The projected CAGR for the next 3 years is 9%.

What is the Pre-Tax Income forecast for CellaVision AB?
Projected CAGR
18%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 20%. The projected CAGR for the next 3 years is 18%.

What is the Net Income forecast for CellaVision AB?
Projected CAGR
18%

Over the last 13 years, the compound annual growth rate for Net Income has been 28%. The projected CAGR for the next 3 years is 18%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett